– U.S. FDA’s Oncologic Drugs Advisory Committee voted 11 to 2 in favor of the clinical benefit of the Phase III POLARIX study of Polivy in combination with R-CHP for people with previously untreated diffuse large B-cell lymphoma – This is the first treatment in 20 years to show a significant and clinically meaningful improvement … [Read more…]

– Clinical data submitted are consistent with global data and support enfortumab vedotin as a platinum-free option in patients with locally advanced or metastatic urothelial cancer who received prior treatment with a PD-1/L1 inhibitor and platinum-based chemotherapy – TOKYO & BOTHELL, Wash.–(BUSINESS WIRE)–Astellas Pharma Inc. (TSE:4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) and Seagen … [Read more…]

NAMUR, Belgium–(BUSINESS WIRE)–Sunrise, the company revolutionising home sleep testing, announces a €17 million in funding. The successful fundraising is led by Kurma Partners and includes the exceptional entry of the European Innovation Council (EIC Fund). The Walloon start-up has also taken an important step by obtaining approval from the European (MDR) and American (FDA) medical … [Read more…]

Anita Haas, Inspirational Teacher and Advocate for Neurodiverse Students, Wins MINNDEPENDENT’s 2023 Honor Teacher Award. GOLDEN VALLEY, Minn.–(BUSINESS WIRE)–Franklin Center teacher Anita Haas has been named the recipient of MINNDEPENDENT’s 2023 Honor Teacher Award. This prestigious award recognizes exceptional teachers who have a passion for students and education. Winners of the Honor Teacher Award are … [Read more…]

BROOMFIELD, Colo.–(BUSINESS WIRE)–TransLogic™, a Swisslog Healthcare company and a leading supplier in transport automation, will participate at the 2023 PDC Summit from March 12-15 in Phoenix, Arizona. TransLogic™ invites attendees from all disciplines of healthcare to learn about the showcased services and solutions as well as experience a laser focused market message. In their new … [Read more…]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) (“Merrimack” or the “Company”) today announced its full year 2022 financial results for the period ended December 31, 2022. “We are encouraged by the results of the NAPOLI 3 trial as reported by Ipsen in November 2022 and the guidance that Ipsen has subsequently provided regarding its intention … [Read more…]

SOMERSET, N.J.–(BUSINESS WIRE)–Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced that members of its executive leadership team will participate at two upcoming investor conferences. On March 14, 2023 at 10:45 a.m. ET, the Company will present at the Barclays Global Healthcare Conference. On … [Read more…]

FOSTER CITY, Calif.–(BUSINESS WIRE)–Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that it will release its fourth quarter and full-year 2022 financial results after the market closes on Thursday, March 16, 2023 via press release, which will be available on the Company’s website at www.geron.com/investors. Geron will host a conference call to … [Read more…]

LOS ANGELES–(BUSINESS WIRE)–AIDS Healthcare Foundation (AHF) strongly condemns the new 10-point plan and partnership the drug industry has cooked up with community health centers as a dangerous deal designed to destroy the 340B Drug Pricing Program, a vital part of the U.S. health care safety net. “PhRMA set a trap, and the National Association of … [Read more…]

Acquisition will make electron capture dissociation (ECD) technology available to more biopharma researchers and labs globally SANTA CLARA, Calif.–(BUSINESS WIRE)–Agilent Technologies Inc. (NYSE: A) today announced the acquisition of e-MSion, an early-stage company behind the innovative electron capture dissociation (ECD) technology known as the ExD cell. The ExD cell is a compact device for mass … [Read more…]